TCT-402 Relationship between Bioresorbable Scaffold Sizing and Scaffold Thrombosis: a Pooled Analysis of ABSORB Trials

Patrick W. Serruys

doi:10.1016/j.jacc.2016.09.537

Related publications

Article2016

TCT-60 1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials

Ariel Furer, Ori Ben‐Yehuda, Björn Redfors, Patrick W. Serruys, Runlin Gao, Takeshi Kimura, Dean J. Kereiakes, Stephen G. Ellis, Weiying Zhao, Minh-Thien Vu, Yoshinobu Onuma, Gregg W. Stone

Journal of the American College of Cardiology

Article2013

TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

Takashi Muramatsu, Yoshinobu Onuma, Robert J. Van Geuns, Bernard Chevalier, Tejas Patel, Ashok Seth, Roberto Diletti, Héctor M. García‐García, Cécile Dorange, Susan Veldhof, Wai‐Fung Cheong, Robert Whitbourn, Antonio L. Bartorelli, Alexandre Abizaid, Patrick W. Serruys

Journal of the American College of Cardiology

Article2016

RELATION BETWEEN BIORESORBABLE SCAFFOLD SIZING USING QCA-DMAX AND CLINICAL OUTCOMES AT 2 YEARS IN 1192 PATIENTS FROM THREE STUDY COHORTS (ABSORB COHORT B, ABSORB EXTEND AND ABSORB II)

Yoshinobu Onuma, Yohei Sotomi, Pannipa Suwannasom, Antonio L. Bartorelli, Robert Whitbourn, Bernard Chevalier, Alexandre Abizaid, John Ormiston, Richard Rapoza, Susan Veldhof, Patrick W. Serruys

Journal of the American College of Cardiology

Article2014

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold

Bernard De Bruyne, Gábor G. Tóth, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2016

TCT-431 RANDOMIZED COMPARISON OF ABSORB BIORESORBABLE VASCULAR SCAFFOLD AND MIRAGE MICROFIBER SIROLIMUS ELUTING SCAFFOLD USING MULTI-MODALITY IMAGING

Teguh Santoso, Huong Bang Liew, Erhan Tenekecioğlu, Ricardo A. Costa, Daniel Chamié, Solomon Su, Alexandre Abizaid, Christos V. Bourantas, Ryo Torii, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

TCT-402 Relationship between Bioresorbable Scaffold Sizing and Scaffold Thrombosis: a Pooled Analysis of ABSORB Trials

Abstract

Discussion(0)

Related publications

TCT-60 1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials

TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials.

RELATION BETWEEN BIORESORBABLE SCAFFOLD SIZING USING QCA-DMAX AND CLINICAL OUTCOMES AT 2 YEARS IN 1192 PATIENTS FROM THREE STUDY COHORTS (ABSORB COHORT B, ABSORB EXTEND AND ABSORB II)

TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold

TCT-431 RANDOMIZED COMPARISON OF ABSORB BIORESORBABLE VASCULAR SCAFFOLD AND MIRAGE MICROFIBER SIROLIMUS ELUTING SCAFFOLD USING MULTI-MODALITY IMAGING